Maravai Lifesciences Holdings Inc Cash Flow Quality Index
Maravai Lifesciences Holdings Inc cash flow quality index. Maravai Lifesciences Holdings Inc (MRVI) has a Cash Flow Quality Index of 1.14x as of December 2022. Operating cash flow of $99.33 Million exceeds net income of $87.43 Million, indicating high earnings quality where cash backs reported profits. See Maravai Lifesciences Holdings Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Maravai Lifesciences Holdings Inc (2020–2022)
Cash flow quality index of Maravai Lifesciences Holdings Inc from 2020 to 2022. Historical Cash Flow Quality Index for Maravai Lifesciences Holdings Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Maravai Lifesciences Holdings Inc (MRVI) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Maravai Lifesciences Holdings Inc Cash Flow Quality Index by Year (2020–2022)
Maravai Lifesciences Holdings Inc cash flow quality index by year from 2020 to 2022. Year-by-year earnings quality comparison for Maravai Lifesciences Holdings Inc. For the full cash flow conversion analysis, see MRVI cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.09x | $535.98 Million | $490.66 Million | ▲ +39.1% |
| 2021 | 0.79x | $368.57 Million | $469.25 Million | ▼ -59.3% |
| 2020 | 1.93x | $152.19 Million | $78.82 Million | — |